$10.06
-0.13-1.28%
At close: -
$10.06
0.000.00%
After Hours: 6:00 PM EDT
Comments
Loading...
Roivant Sciences Analyst Ratings and Price Targets | NASDAQ:ROIV | Benzinga
Roivant Sciences Ltd has a consensus price target of $16.41 based on the ratings of 12 analysts. The high is $23 issued by Truist Securities on March 25, 2024. The low is $10 issued by SVB Leerink on December 19, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on February 11, 2025, November 13, 2024, and September 19, 2024, respectively. With an average price target of $18 between HC Wainwright & Co., there's an implied 78.93% upside for Roivant Sciences Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
B of A Securities
Piper Sandler
Goldman Sachs
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for Roivant Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/11/2025 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen51% | — | Reiterates | → Overweight | Get Alert |
| 09/19/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 09/11/2024 | Buy Now | 24.25% | B of A Securities | Chi Fong26% | $12 → $12.5 | Maintains | Neutral | Get Alert |
| 09/11/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen51% | — | Reiterates | → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2024 | Buy Now | 118.69% | Piper Sandler | Allison Bratzel58% | $20 → $22 | Maintains | Overweight | Get Alert |
| 06/18/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen51% | — | Reiterates | → Overweight | Get Alert |
| 05/31/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | 78.93% | Goldman Sachs | Corinne Jenkins47% | $16 → $18 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $17 → $18 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 49.11% | Deutsche Bank | Neena Bitritto-Garg60% | $14 → $15 | Maintains | Buy | Get Alert |
| 03/25/2024 | Buy Now | 128.63% | Truist Securities | Robyn Karnauskas55% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 02/15/2024 | Buy Now | 68.99% | Wolfe Research | Andy Chen32% | → $17 | Initiates | → Outperform | Get Alert |
| 02/14/2024 | Buy Now | 68.99% | HC Wainwright & Co. | Douglas Tsao49% | $18 → $17 | Maintains | Buy | Get Alert |
| 01/05/2024 | Buy Now | 98.81% | Piper Sandler | Allison Bratzel58% | → $20 | Initiates | → Overweight | Get Alert |
| 01/02/2024 | Buy Now | 19.28% | B of A Securities | Chi Fong26% | $11 → $12 | Maintains | Neutral | Get Alert |
| 12/12/2023 | Buy Now | 39.17% | Deutsche Bank | Neena Bitritto-Garg60% | → $14 | Initiates | → Buy | Get Alert |
| 11/15/2023 | Buy Now | 59.05% | Guggenheim | Yatin Suneja46% | $17 → $16 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | 49.11% | JP Morgan | Brian Cheng37% | $16 → $15 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | 68.99% | Guggenheim | Yatin Suneja46% | → $17 | Initiates | → Buy | Get Alert |
| 09/27/2023 | Buy Now | 59.05% | Goldman Sachs | Corinne Jenkins47% | $14 → $16 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 128.63% | Truist Securities | Robyn Karnauskas55% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 09/18/2023 | Buy Now | 49.11% | Cantor Fitzgerald | Louise Chen51% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | Buy Now | 49.11% | Cantor Fitzgerald | Louise Chen51% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | Buy Now | 49.11% | Cantor Fitzgerald | Louise Chen51% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 49.11% | Cantor Fitzgerald | Louise Chen51% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 07/14/2023 | Buy Now | 128.63% | Truist Securities | Robyn Karnauskas55% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | Buy Now | 78.93% | HC Wainwright & Co. | Douglas Tsao49% | $15 → $18 | Maintains | Buy | Get Alert |
| 06/23/2023 | Buy Now | 128.63% | Truist Securities | Robyn Karnauskas55% | $19 → $23 | Maintains | Buy | Get Alert |
| 06/23/2023 | Buy Now | 49.11% | HC Wainwright & Co. | Douglas Tsao49% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 49.11% | Cantor Fitzgerald | Louise Chen51% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 06/08/2023 | Buy Now | 4.37% | B of A Securities | Chi Fong26% | → $10.5 | Initiates | → Neutral | Get Alert |
| 05/18/2023 | Buy Now | 39.17% | JP Morgan | Brian Cheng37% | $12 → $14 | Maintains | Overweight | Get Alert |
| 05/17/2023 | Buy Now | 49.11% | HC Wainwright & Co. | Douglas Tsao49% | $14 → $15 | Maintains | Buy | Get Alert |
| 05/12/2023 | Buy Now | 39.17% | HC Wainwright & Co. | Douglas Tsao49% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/29/2023 | Buy Now | 19.28% | JP Morgan | Brian Cheng37% | → $12 | Maintains | Overweight | Get Alert |
| 03/16/2023 | Buy Now | 39.17% | HC Wainwright & Co. | Douglas Tsao49% | → $14 | Reiterates | → Buy | Get Alert |
| 02/14/2023 | Buy Now | 39.17% | HC Wainwright & Co. | Douglas Tsao49% | → $14 | Reiterates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | 9.34% | JP Morgan | Brian Cheng37% | $10 → $11 | Maintains | Overweight | Get Alert |
| 01/19/2023 | Buy Now | 9.34% | Goldman Sachs | Corinne Jenkins47% | $10 → $11 | Maintains | Buy | Get Alert |
| 01/10/2023 | Buy Now | -0.6% | JP Morgan | Brian Cheng37% | $9 → $10 | Maintains | Overweight | Get Alert |
| 01/05/2023 | Buy Now | 39.17% | Citigroup | Neena Bitritto-Garg60% | $11 → $14 | Maintains | Buy | Get Alert |
| 12/19/2022 | Buy Now | -0.6% | SVB Leerink | David Risinger72% | $8 → $10 | Maintains | Outperform | Get Alert |
| 12/12/2022 | Buy Now | -10.54% | JP Morgan | Brian Cheng37% | → $9 | Maintains | Overweight | Get Alert |
| 11/15/2022 | Buy Now | 9.34% | Citigroup | Neena Bitritto-Garg60% | $10 → $11 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | -20.48% | SVB Leerink | David Risinger72% | $7 → $8 | Maintains | Outperform | Get Alert |
| 08/16/2022 | Buy Now | -0.6% | Citigroup | Neena Bitritto-Garg60% | $9 → $10 | Maintains | Buy | Get Alert |
| 06/29/2022 | Buy Now | -30.42% | SVB Leerink | David Risinger72% | $6 → $7 | Maintains | Outperform | Get Alert |
| 05/24/2022 | Buy Now | 19.28% | Goldman Sachs | Corinne Jenkins47% | $15 → $12 | Maintains | Buy | Get Alert |
| 05/23/2022 | Buy Now | -40.36% | SVB Leerink | David Risinger72% | → $6 | Initiates | → Outperform | Get Alert |
| 04/29/2022 | Buy Now | 49.11% | Cantor Fitzgerald | Louise Chen51% | → $15 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Roivant Sciences (ROIV) stock?
The latest price target for Roivant Sciences (NASDAQ:ROIV) was reported by HC Wainwright & Co. on February 11, 2025. The analyst firm set a price target for $18.00 expecting ROIV to rise to within 12 months (a possible 78.93% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Roivant Sciences (ROIV)?
The latest analyst rating for Roivant Sciences (NASDAQ:ROIV) was provided by HC Wainwright & Co., and Roivant Sciences reiterated their buy rating.
When was the last upgrade for Roivant Sciences (ROIV)?
There is no last upgrade for Roivant Sciences
When was the last downgrade for Roivant Sciences (ROIV)?
There is no last downgrade for Roivant Sciences.
When is the next analyst rating going to be posted or updated for Roivant Sciences (ROIV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Roivant Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Roivant Sciences was filed on February 11, 2025 so you should expect the next rating to be made available sometime around February 11, 2026.
Is the Analyst Rating Roivant Sciences (ROIV) correct?
While ratings are subjective and will change, the latest Roivant Sciences (ROIV) rating was a reiterated with a price target of $18.00 to $18.00. The current price Roivant Sciences (ROIV) is trading at is $10.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.